# Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

> **NCT01596530** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 3 (actual)

## Conditions studied

- Breast Neoplasm

## Interventions

- **DRUG:** Drug-AZD8931
- **DRUG:** Drug-Placebo

## Key facts

- **NCT ID:** NCT01596530
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** All AstraZeneca sponsored clinical trials of AZD8931 have been halted
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596530, "Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01596530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*